Molecular events associated with resistance to tyrosine kinase inhibitors in leukemia cells.
T Hrdinová - 2022 - dspace.cuni.cz
Chronic myeloid leukemia (CML) is a myeloproliferative stem cell disease characterized by
the expression of BCR-ABL oncoprotein with constitutive tyrosine kinase activity. Although …
the expression of BCR-ABL oncoprotein with constitutive tyrosine kinase activity. Although …
Molecular events associated with resistance to tyrosine kinase inhibitors in leukemia cells.
T Hrdinová - 2022 - dspace.cuni.cz
Chronic myeloid leukemia (CML) is a myeloproliferative stem cell disease characterized by
the expression of BCR-ABL oncoprotein with constitutive tyrosine kinase activity. Although …
the expression of BCR-ABL oncoprotein with constitutive tyrosine kinase activity. Although …